Literature DB >> 31300970

What will the future hold for artificial organs in the service of assisted reproduction: prospects and considerations.

Mara Simopoulou1,2, Konstantinos Sfakianoudis3, Petroula Tsioulou4, Anna Rapani4, Polina Giannelou4,3, Nikolaos Kiriakopoulos4, Agni Pantou3, Nikolaos Vlahos4, George Anifandis5, Stamatis Bolaris6, Konstantinos Pantos3, Michael Koutsilieris4.   

Abstract

Assisted reproduction provides a wide spectrum of treatments and strategies addressing infertility. However, distinct groups of infertile patients with unexplained infertility, congenital disorders, and other complex cases pose a challenge in in vitro fertilization (IVF) practices. This special cohort of patients is associated with futile attempts, IVF overuse, and dead ends in management. Cutting edge research on animal models introduced this concept, along with the development of artificial organs with the aim to mimic the respective physiological functions in reproduction. Extrapolation on clinical application leads to the future use of infertility management in humans. To date, the successful clinical application of artificial reproductive organs in humans is not feasible because further animal model studies are required prior to clinical trials. The application of these artificial organs could provide a solution to infertility cases with no other options. This manuscript presents an overview on the current status, future prospects, and considerations on the potential clinical application of artificial ovary, uterus, and gametes in humans. This paper presents how the IVF practice landscape may be shaped and challenged in the future, along with the subsequent concerns in assisted reproductive treatments.

Entities:  

Keywords:  artificial gametes; artificial ovary; artificial uterus; assisted reproduction; considerations; in vitro fertilization

Mesh:

Year:  2019        PMID: 31300970     DOI: 10.1007/s11684-019-0697-5

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  87 in total

Review 1.  Ovarian tissue cryopreservation: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2014-03-28       Impact factor: 7.329

2.  3D-printed biological organs: medical potential and patenting opportunity.

Authors:  Seung-Schik Yoo
Journal:  Expert Opin Ther Pat       Date:  2015-02-24       Impact factor: 6.674

3.  Ovarian tissue vitrification is more efficient than slow freezing in protecting oocyte and granulosa cell DNA integrity.

Authors:  Freya Jothsna Mathias; Fiona D'Souza; Shubhashree Uppangala; Sujith Raj Salian; Guruprasad Kalthur; Satish Kumar Adiga
Journal:  Syst Biol Reprod Med       Date:  2014-06-04       Impact factor: 3.061

4.  A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients.

Authors:  Konstantinos Sfakianoudis; Mara Simopoulou; Nikolaos Nitsos; Anna Rapani; Agni Pantou; Terpsithea Vaxevanoglou; Georgia Kokkali; Michael Koutsilieris; Konstantinos Pantos
Journal:  Gynecol Obstet Invest       Date:  2018-08-22       Impact factor: 2.031

5.  What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction.

Authors:  Jason K Min; Sue A Breheny; Vivien MacLachlan; David L Healy
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

6.  In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technological advancement.

Authors:  Jeff Wang; Mark V Sauer
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

Review 7.  Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment.

Authors:  B Meczekalski; A Czyzyk; M Kunicki; A Podfigurna-Stopa; L Plociennik; G Jakiel; M Maciejewska-Jeske; K Lukaszuk
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

Review 8.  Current clinical applications of platelet-rich plasma in various gynecological disorders: An appraisal of theory and practice.

Authors:  Ayman Shehata Dawood; Hesham Abdelaziz Salem
Journal:  Clin Exp Reprod Med       Date:  2018-06-29

9.  Uterine transplantation in transgender women.

Authors:  B P Jones; N J Williams; S Saso; M-Y Thum; I Quiroga; J Yazbek; S Wilkinson; S Ghaem-Maghami; P Thomas; J R Smith
Journal:  BJOG       Date:  2018-09-20       Impact factor: 6.531

10.  Synthetic hydrogel supports the function and regeneration of artificial ovarian tissue in mice.

Authors:  Jiwon Kim; Amanda S Perez; Jake Claflin; Anu David; Hong Zhou; Ariella Shikanov
Journal:  NPJ Regen Med       Date:  2016-07-07
View more
  1 in total

Review 1.  Novel Approaches in Addressing Ovarian Insufficiency in 2019: Are We There Yet?

Authors:  Konstantinos Sfakianoudis; Anna Rapani; Sokratis Grigoriadis; Dimitra Retsina; Evangelos Maziotis; Petroula Tsioulou; Polina Giannelou; Konstantinos Pantos; Michael Koutsilieris; Nikolaos Vlahos; George Mastorakos; Mara Simopoulou
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.